45 CFR § 180 compliance
B · 85
This hospital published most of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
●Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
16,305
Insurances with rates
35
CPT / HCPCS codes
0
Source MRF
Most expensive procedures (gross)
J022500000
$345,212
Vutrisiran 25mg/0.5ml Syringe
Gross
$363,381
J022500000
$345,212
Vutrisiran 25mg/0.5ml Syringe
Gross
$363,381
J022500000
$345,212
Vutrisiran 25mg/0.5ml Syringe
Gross
$363,381
J182300000
$135,219
Inebilizumab-cdon 100mg/10ml
Gross
$142,335
J182300000
$135,219
Inebilizumab-cdon 100mg/10ml
Gross
$142,335
J182300000
$135,219
Inebilizumab-cdon 100mg/10ml
Gross
$142,335
J235100000
$119,404
Ocrelizumab Hyal-ocsq 920mg Vl
Gross
$125,689
J235100000
$119,404
Ocrelizumab Hyal-ocsq 920mg Vl
Gross
$125,689
J235100000
$119,404
Ocrelizumab Hyal-ocsq 920mg Vl
Gross
$125,689
J934700000
$117,361
Tremelimumab-ACTL 300mg/15ml
Gross
$123,538
J934700000
$117,361
Tremelimumab-ACTL 300mg/15ml
Gross
$123,538
J934700000
$117,361
Tremelimumab-ACTL 300mg/15ml
Gross
$123,538
J922800000
$89,412
Ipilimumab 200mg Vial
Gross
$94,117
J922800000
$89,412
Ipilimumab 200mg Vial
Gross
$94,117
J922800000
$89,412
Ipilimumab 200mg Vial
Gross
$94,117
J717000002
$87,426
Emicizumab-kxwh 300mg/2mL Vial
Gross
$92,028
J717000002
$87,426
Emicizumab-kxwh 300mg/2mL Vial
Gross
$92,028
J717000002
$87,426
Emicizumab-kxwh 300mg/2mL Vial
Gross
$92,028
C172200010
$85,647
AICD Single Chamber VASC
Gross
$90,155
C172200010
$85,647
AICD Single Chamber VASC
Gross
$90,155
C172200010
$85,647
AICD Single Chamber VASC
Gross
$90,155
C176700013
$81,581
Genertr Neuro Non-Rechrg PAIN
Gross
$85,875
C176700013
$81,581
Genertr Neuro Non-Rechrg PAIN
Gross
$85,875
C176700013
$81,581
Genertr Neuro Non-Rechrg PAIN
Gross
$85,875
C176700012
$81,498
Genertr Neuro Non-Rechrg NEURO
Gross
$85,788
C176700012
$81,498
Genertr Neuro Non-Rechrg NEURO
Gross
$85,788
C176700012
$81,498
Genertr Neuro Non-Rechrg NEURO
Gross
$85,788
C182200003
$76,000
Gen Neuro HF Rechg Bat PAIN
Gross
$80,000
C182200003
$76,000
Gen Neuro HF Rechg Bat PAIN
Gross
$80,000
C182200003
$76,000
Gen Neuro HF Rechg Bat PAIN
Gross
$80,000
C188200002
$71,920
AICD Othr Than Sing/Dual PACER
Gross
$75,705
C188200002
$71,920
AICD Othr Than Sing/Dual PACER
Gross
$75,705
C188200002
$71,920
AICD Othr Than Sing/Dual PACER
Gross
$75,705
J935900000
$67,972
Loncastuximab-Lpyl 10mg Vial
Gross
$71,549
J935900000
$67,972
Loncastuximab-Lpyl 10mg Vial
Gross
$71,549
J935900000
$67,972
Loncastuximab-Lpyl 10mg Vial
Gross
$71,549
J130300000
$67,918
Ravulizumab-CWVZ 1100mg vial
Gross
$71,492
J130300000
$67,918
Ravulizumab-CWVZ 1100mg vial
Gross
$71,492
J130300000
$67,918
Ravulizumab-CWVZ 1100mg vial
Gross
$71,492
J927400000
$60,712
Tebentafusp-TEBN 100mcg/0.5ml
Gross
$63,907
J927400000
$60,712
Tebentafusp-TEBN 100mcg/0.5ml
Gross
$63,907
J927400000
$60,712
Tebentafusp-TEBN 100mcg/0.5ml
Gross
$63,907
J250700000
$59,072
Pegloticase 8Mg Vial
Gross
$62,181
J250700000
$59,072
Pegloticase 8Mg Vial
Gross
$62,181
J250700000
$59,072
Pegloticase 8Mg Vial
Gross
$62,181
C182000007
$54,625
Gen Neuro Rechg Bat Sys PAIN
Gross
$57,500
C182000007
$54,625
Gen Neuro Rechg Bat Sys PAIN
Gross
$57,500
C182000007
$54,625
Gen Neuro Rechg Bat Sys PAIN
Gross
$57,500
J933300000
$53,818
Rozanolixizumab-noli 840mg/6ml
Gross
$56,650
J933300000
$53,818
Rozanolixizumab-noli 840mg/6ml
Gross
$56,650
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J022500000 | Vutrisiran 25mg/0.5ml Syringe | $363,381 | $345,212 | — | — | 5 |
| J022500000 | Vutrisiran 25mg/0.5ml Syringe | $363,381 | $345,212 | — | — | 12 |
| J022500000 | Vutrisiran 25mg/0.5ml Syringe | $363,381 | $345,212 | — | — | 18 |
| J182300000 | Inebilizumab-cdon 100mg/10ml | $142,335 | $135,219 | — | — | 5 |
| J182300000 | Inebilizumab-cdon 100mg/10ml | $142,335 | $135,219 | — | — | 12 |
| J182300000 | Inebilizumab-cdon 100mg/10ml | $142,335 | $135,219 | — | — | 18 |
| J235100000 | Ocrelizumab Hyal-ocsq 920mg Vl | $125,689 | $119,404 | — | — | 5 |
| J235100000 | Ocrelizumab Hyal-ocsq 920mg Vl | $125,689 | $119,404 | — | — | 12 |
| J235100000 | Ocrelizumab Hyal-ocsq 920mg Vl | $125,689 | $119,404 | — | — | 18 |
| J934700000 | Tremelimumab-ACTL 300mg/15ml | $123,538 | $117,361 | — | — | 5 |
| J934700000 | Tremelimumab-ACTL 300mg/15ml | $123,538 | $117,361 | — | — | 12 |
| J934700000 | Tremelimumab-ACTL 300mg/15ml | $123,538 | $117,361 | — | — | 18 |
| J922800000 | Ipilimumab 200mg Vial | $94,117 | $89,412 | — | — | 5 |
| J922800000 | Ipilimumab 200mg Vial | $94,117 | $89,412 | — | — | 12 |
| J922800000 | Ipilimumab 200mg Vial | $94,117 | $89,412 | — | — | 18 |
| J717000002 | Emicizumab-kxwh 300mg/2mL Vial | $92,028 | $87,426 | — | — | 5 |
| J717000002 | Emicizumab-kxwh 300mg/2mL Vial | $92,028 | $87,426 | — | — | 12 |
| J717000002 | Emicizumab-kxwh 300mg/2mL Vial | $92,028 | $87,426 | — | — | 18 |
| C172200010 | AICD Single Chamber VASC | $90,155 | $85,647 | — | — | 5 |
| C172200010 | AICD Single Chamber VASC | $90,155 | $85,647 | — | — | 12 |
| C172200010 | AICD Single Chamber VASC | $90,155 | $85,647 | — | — | 13 |
| C176700013 | Genertr Neuro Non-Rechrg PAIN | $85,875 | $81,581 | — | — | 5 |
| C176700013 | Genertr Neuro Non-Rechrg PAIN | $85,875 | $81,581 | — | — | 12 |
| C176700013 | Genertr Neuro Non-Rechrg PAIN | $85,875 | $81,581 | — | — | 13 |
| C176700012 | Genertr Neuro Non-Rechrg NEURO | $85,788 | $81,498 | — | — | 5 |
| C176700012 | Genertr Neuro Non-Rechrg NEURO | $85,788 | $81,498 | — | — | 12 |
| C176700012 | Genertr Neuro Non-Rechrg NEURO | $85,788 | $81,498 | — | — | 13 |
| C182200003 | Gen Neuro HF Rechg Bat PAIN | $80,000 | $76,000 | — | — | 5 |
| C182200003 | Gen Neuro HF Rechg Bat PAIN | $80,000 | $76,000 | — | — | 12 |
| C182200003 | Gen Neuro HF Rechg Bat PAIN | $80,000 | $76,000 | — | — | 13 |
| C188200002 | AICD Othr Than Sing/Dual PACER | $75,705 | $71,920 | — | — | 5 |
| C188200002 | AICD Othr Than Sing/Dual PACER | $75,705 | $71,920 | — | — | 12 |
| C188200002 | AICD Othr Than Sing/Dual PACER | $75,705 | $71,920 | — | — | 13 |
| J935900000 | Loncastuximab-Lpyl 10mg Vial | $71,549 | $67,972 | — | — | 5 |
| J935900000 | Loncastuximab-Lpyl 10mg Vial | $71,549 | $67,972 | — | — | 12 |
| J935900000 | Loncastuximab-Lpyl 10mg Vial | $71,549 | $67,972 | — | — | 18 |
| J130300000 | Ravulizumab-CWVZ 1100mg vial | $71,492 | $67,918 | — | — | 5 |
| J130300000 | Ravulizumab-CWVZ 1100mg vial | $71,492 | $67,918 | — | — | 12 |
| J130300000 | Ravulizumab-CWVZ 1100mg vial | $71,492 | $67,918 | — | — | 18 |
| J927400000 | Tebentafusp-TEBN 100mcg/0.5ml | $63,907 | $60,712 | — | — | 5 |
| J927400000 | Tebentafusp-TEBN 100mcg/0.5ml | $63,907 | $60,712 | — | — | 12 |
| J927400000 | Tebentafusp-TEBN 100mcg/0.5ml | $63,907 | $60,712 | — | — | 18 |
| J250700000 | Pegloticase 8Mg Vial | $62,181 | $59,072 | — | — | 5 |
| J250700000 | Pegloticase 8Mg Vial | $62,181 | $59,072 | — | — | 12 |
| J250700000 | Pegloticase 8Mg Vial | $62,181 | $59,072 | — | — | 18 |
| C182000007 | Gen Neuro Rechg Bat Sys PAIN | $57,500 | $54,625 | — | — | 5 |
| C182000007 | Gen Neuro Rechg Bat Sys PAIN | $57,500 | $54,625 | — | — | 12 |
| C182000007 | Gen Neuro Rechg Bat Sys PAIN | $57,500 | $54,625 | — | — | 13 |
| J933300000 | Rozanolixizumab-noli 840mg/6ml | $56,650 | $53,818 | — | — | 5 |
| J933300000 | Rozanolixizumab-noli 840mg/6ml | $56,650 | $53,818 | — | — | 12 |
Showing top 50 of 16,305 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.